Premium
CYP2B6 ‐G516T genotype influences plasma efavirenz concentration in a H ong K ong population, allowing potential individualization of therapy
Author(s) -
Naftalin CM,
Chan KCW,
Wong KH,
Cheung SW,
Chan RCY,
Lee SS
Publication year - 2014
Publication title -
hiv medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.53
H-Index - 79
eISSN - 1468-1293
pISSN - 1464-2662
DOI - 10.1111/hiv.12076
Subject(s) - efavirenz , cyp2b6 , medicine , pharmacology , genotype , regimen , therapeutic drug monitoring , population , asymptomatic , genotyping , gastroenterology , viral load , pharmacokinetics , immunology , antiretroviral therapy , human immunodeficiency virus (hiv) , biology , genetics , metabolism , cytochrome p450 , environmental health , gene , cyp3a4